{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/49072"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/49072","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The effects of amyloid precursor protein C-105 expression and ganglioside GM1 on PC12 cell vulnerability to the calcium ionophore A23 187 and hydrogen peroxide","abstract":"Specific mutations in the gene for the beta amyloid precursor protein (APP) cause Alzheimer's disease (AD). A key neuropathological hallmark of AD is extracellular neuritic plaques. The core component of plaques is AB, a 39-43 amino acid peptide derived from APP. APP C-100 and APP C-105 are C-terminal fragments of APP, 100 and 105 amino acids long, respectively. APP C-100 is a normal metabolite of APP. AI3 is located at the N-terminus of the APP C-100 sequence. To determine whether APP C-105 expression alters cellular vulnerability to calcium and hydrogen peroxide, rat PC12 cells were modified to overexpress APP C-105. Permanent transfectants (clones) were selected, then characterized by standard molecular biological techniques. DNA and mRNA corresponding to APP C-105 were detected in APP C-105 transfectants, but not in wild type controls. Aggregated APP C-105 was detected in cell lysates and conditioned media from APP C-105 transfectants, but was absent or detected at lower concentrations in vector-transfected and wild type controls. Cell survival as a function of concentration was determined for A23 l 87, a Ca^2+ ionophore, and hydrogen peroxide in APP C-105 transfectants and vector-transfected controls. Cells were exposed to A23 l 87 or hydrogen peroxide for 24 hours in RP:MI media containing 3 μM insulin, and survival was quantitated using the tetrazolium dye, MTT. APP C-105 expression significantly increased PC 12 cell vulnerability to A23 l 87, and significantly decreased vulnerability to hydrogen peroxide. Other experiments were performed with GM 1 ganglioside, which is known to protect cells against numerous insults. When wild type PC 12 cells or APP C-10 5 transfectants were exposed to a toxin and GMl concurrently for 24 hours, GMl produced concentration-dependent inhibition of A23 l 87 toxicity in wild type PC 12 cells but was ineffective against hydrogen peroxide in both wild type PC12 and APP C-105-transfected clones. The current study has demonstrated that expression of APP C-105 protects PC 12 cells against hydrogen peroxide, but exacerbates the effect of calcium influx. In conjunction with other reports, this study indicates that APP C-105 is an important regulator of cellular homeostasis. Therefore, the pattern of APP processing may alter vulnerability to neurotoxic insults.","abstract_html":"Specific mutations in the gene for the beta amyloid precursor protein (APP) cause Alzheimer&#x27;s disease (AD). A key neuropathological hallmark of AD is extracellular neuritic plaques. The core component of plaques is AB, a 39-43 amino acid peptide derived from APP. APP C-100 and APP C-105 are C-terminal fragments of APP, 100 and 105 amino acids long, respectively. APP C-100 is a normal metabolite of APP. AI3 is located at the N-terminus of the APP C-100 sequence. To determine whether APP C-105 expression alters cellular vulnerability to calcium and hydrogen peroxide, rat PC12 cells were modified to overexpress APP C-105. Permanent transfectants (clones) were selected, then characterized by standard molecular biological techniques. DNA and mRNA corresponding to APP C-105 were detected in APP C-105 transfectants, but not in wild type controls. Aggregated APP C-105 was detected in cell lysates and conditioned media from APP C-105 transfectants, but was absent or detected at lower concentrations in vector-transfected and wild type controls. Cell survival as a function of concentration was determined for A23 l 87, a Ca^2+ ionophore, and hydrogen peroxide in APP C-105 transfectants and vector-transfected controls. Cells were exposed to A23 l 87 or hydrogen peroxide for 24 hours in RP:MI media containing 3 μM insulin, and survival was quantitated using the tetrazolium dye, MTT. APP C-105 expression significantly increased PC 12 cell vulnerability to A23 l 87, and significantly decreased vulnerability to hydrogen peroxide. Other experiments were performed with GM 1 ganglioside, which is known to protect cells against numerous insults. When wild type PC 12 cells or APP C-10 5 transfectants were exposed to a toxin and GMl concurrently for 24 hours, GMl produced concentration-dependent inhibition of A23 l 87 toxicity in wild type PC 12 cells but was ineffective against hydrogen peroxide in both wild type PC12 and APP C-105-transfected clones. The current study has demonstrated that expression of APP C-105 protects PC 12 cells against hydrogen peroxide, but exacerbates the effect of calcium influx. In conjunction with other reports, this study indicates that APP C-105 is an important regulator of cellular homeostasis. Therefore, the pattern of APP processing may alter vulnerability to neurotoxic insults.","abstract_has_math":false,"creators":["O'Malley, Catherine McKeon"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Pharmacology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1997,"date_issued":"1997","date_published":"1997","updated_at":"2026-11-18T20:10:43Z","subjects":["Pharmacology","Alzheimer's disease","Neuropathology","Psychiatry"],"languages":["en_US"],"rights":["This work is being made available in OpenBU by permission of its author, and is available for research purposes only. All rights are reserved to the author."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/49072","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/49072","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F49072","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["O'Malley, Catherine McKeon"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-07-11T17:50:30Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-07-11T17:50:30Z"]},{"key":"dc:date.issued","label":"Date","values":["1997"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmacology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University School of Medicine"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pharmacology","Alzheimer's disease","Neuropathology","Psychiatry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["This work is being made available in OpenBU by permission of its author, and is available for research purposes only. All rights are reserved to the author."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/49072"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Specific mutations in the gene for the beta amyloid precursor protein (APP) cause Alzheimer's disease (AD). A key neuropathological hallmark of AD is extracellular neuritic plaques. The core component of plaques is AB, a 39-43 amino acid peptide derived from APP. APP C-100 and APP C-105 are C-terminal fragments of APP, 100 and 105 amino acids long, respectively. APP C-100 is a normal metabolite of APP. AI3 is located at the N-terminus of the APP C-100 sequence. To determine whether APP C-105 expression alters cellular vulnerability to calcium and hydrogen peroxide, rat PC12 cells were modified to overexpress APP C-105. Permanent transfectants (clones) were selected, then characterized by standard molecular biological techniques. DNA and mRNA corresponding to APP C-105 were detected in APP C-105 transfectants, but not in wild type controls. Aggregated APP C-105 was detected in cell lysates and conditioned media from APP C-105 transfectants, but was absent or detected at lower concentrations in vector-transfected and wild type controls. Cell survival as a function of concentration was determined for A23 l 87, a Ca^2+ ionophore, and hydrogen peroxide in APP C-105 transfectants and vector-transfected controls. Cells were exposed to A23 l 87 or hydrogen peroxide for 24 hours in RP:MI media containing 3 μM insulin, and survival was quantitated using the tetrazolium dye, MTT. APP C-105 expression significantly increased PC 12 cell vulnerability to A23 l 87, and significantly decreased vulnerability to hydrogen peroxide. Other experiments were performed with GM 1 ganglioside, which is known to protect cells against numerous insults. When wild type PC 12 cells or APP C-10 5 transfectants were exposed to a toxin and GMl concurrently for 24 hours, GMl produced concentration-dependent inhibition of A23 l 87 toxicity in wild type PC 12 cells but was ineffective against hydrogen peroxide in both wild type PC12 and APP C-105-transfected clones. The current study has demonstrated that expression of APP C-105 protects PC 12 cells against hydrogen peroxide, but exacerbates the effect of calcium influx. In conjunction with other reports, this study indicates that APP C-105 is an important regulator of cellular homeostasis. Therefore, the pattern of APP processing may alter vulnerability to neurotoxic insults."]},{"key":"dc:title","label":"Title","values":["The effects of amyloid precursor protein C-105 expression and ganglioside GM1 on PC12 cell vulnerability to the calcium ionophore A23 187 and hydrogen peroxide"]}]}],"canonical_facts":{"dc:creator":["O'Malley, Catherine McKeon"],"dc:date.accessioned":["2024-07-11T17:50:30Z"],"dc:date.available":["2024-07-11T17:50:30Z"],"dc:date.issued":["1997"],"dc:description.abstract":["Specific mutations in the gene for the beta amyloid precursor protein (APP) cause Alzheimer's disease (AD). A key neuropathological hallmark of AD is extracellular neuritic plaques. The core component of plaques is AB, a 39-43 amino acid peptide derived from APP. APP C-100 and APP C-105 are C-terminal fragments of APP, 100 and 105 amino acids long, respectively. APP C-100 is a normal metabolite of APP. AI3 is located at the N-terminus of the APP C-100 sequence. To determine whether APP C-105 expression alters cellular vulnerability to calcium and hydrogen peroxide, rat PC12 cells were modified to overexpress APP C-105. Permanent transfectants (clones) were selected, then characterized by standard molecular biological techniques. DNA and mRNA corresponding to APP C-105 were detected in APP C-105 transfectants, but not in wild type controls. Aggregated APP C-105 was detected in cell lysates and conditioned media from APP C-105 transfectants, but was absent or detected at lower concentrations in vector-transfected and wild type controls. Cell survival as a function of concentration was determined for A23 l 87, a Ca^2+ ionophore, and hydrogen peroxide in APP C-105 transfectants and vector-transfected controls. Cells were exposed to A23 l 87 or hydrogen peroxide for 24 hours in RP:MI media containing 3 μM insulin, and survival was quantitated using the tetrazolium dye, MTT. APP C-105 expression significantly increased PC 12 cell vulnerability to A23 l 87, and significantly decreased vulnerability to hydrogen peroxide. Other experiments were performed with GM 1 ganglioside, which is known to protect cells against numerous insults. When wild type PC 12 cells or APP C-10 5 transfectants were exposed to a toxin and GMl concurrently for 24 hours, GMl produced concentration-dependent inhibition of A23 l 87 toxicity in wild type PC 12 cells but was ineffective against hydrogen peroxide in both wild type PC12 and APP C-105-transfected clones. The current study has demonstrated that expression of APP C-105 protects PC 12 cells against hydrogen peroxide, but exacerbates the effect of calcium influx. In conjunction with other reports, this study indicates that APP C-105 is an important regulator of cellular homeostasis. Therefore, the pattern of APP processing may alter vulnerability to neurotoxic insults."],"dc:identifier.uri":["https://hdl.handle.net/2144/49072"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:rights":["This work is being made available in OpenBU by permission of its author, and is available for research purposes only. All rights are reserved to the author."],"dc:subject":["Pharmacology","Alzheimer's disease","Neuropathology","Psychiatry"],"dc:title":["The effects of amyloid precursor protein C-105 expression and ganglioside GM1 on PC12 cell vulnerability to the calcium ionophore A23 187 and hydrogen peroxide"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Pharmacology"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University School of Medicine"]},"updated_at":"2026-11-18T20:10:43Z"}